Consistent with this assumption, depending on the cancer type, in tumour cells expressing DR4 and DR5, both receptors may contribute differently to the enhancement of TRAIL-induced PARP cleavage, as in GMDS-rescued cells [25]. This evidence concerns the gene TNFRSF10A and cancer.